Can Oral Pills Dominate the GLP-1 Market? Novo Nordisk’s Bold Prediction for 2030
Novo Nordisk predicts oral GLP-1s will reshape the weight-loss drug landscape Novo Nordisk has revised its market forecast significantly…
Novo Nordisk predicts oral GLP-1s will reshape the weight-loss drug landscape Novo Nordisk has revised its market forecast significantly…